• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变与人格特征:过去 10 年(2010 至 2020 年)科学证据的系统回顾。

Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).

机构信息

Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, 98121 Messina, Italy.

School and Operative Unit of Allergy and Clinical Immunology, Policlinico "G. Martino", Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

出版信息

Medicina (Kaunas). 2021 Jun 16;57(6):628. doi: 10.3390/medicina57060628.

DOI:10.3390/medicina57060628
PMID:34208694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235071/
Abstract

: to investigate the current state of art in the study of personality disorders in central serous chorioretinopathy (CSC), also taking into account the dimensional approach. : this systematic review was conducted according to PRISMA guidelines. We included articles written in English or Italian, published in peer reviewed journals from 1 January 2010 to 31 December 2020. : after the screening, 10 studies were included. The results suggest that CSC patients are not characterized by the prevalence of a formal personality disorder, but they are better explained by typical personality traits that may alter their relationship with others. CSC patients seems to be characterized by high levels of aggressiveness and anxiety traits along with low sociability. We propose a model of disease where stress exacerbates prior specific traits in a vicious circle where some traits might be involved in disease progression and manifestation. : maladaptive personality traits might be an essential feature of the disease and may represent a possible link between psychiatric symptoms, such as insomnia, anxiety, and depression, and endocrinological patterns. Further research should use a specific assessment scale evaluating both the level of interpersonal functioning and specific maladaptive traits.

摘要

: 旨在调查中心性浆液性脉络膜视网膜病变 (CSC) 患者人格障碍研究的现状,同时考虑到维度方法。: 本系统评价按照 PRISMA 指南进行。我们纳入了 2010 年 1 月 1 日至 2020 年 12 月 31 日发表在同行评审期刊上的英文或意大利文文章。: 经过筛选,共纳入 10 项研究。结果表明,CSC 患者并非以正式人格障碍的患病率为特征,而是更能被典型人格特质所解释,这些特质可能会改变他们与他人的关系。CSC 患者似乎表现出高水平的攻击性和焦虑特质,同时社交能力较低。我们提出了一种疾病模型,其中压力会在一个恶性循环中加剧先前特定的特质,而一些特质可能与疾病的进展和表现有关。: 适应不良的人格特质可能是疾病的一个重要特征,并且可能是精神症状(如失眠、焦虑和抑郁)与内分泌模式之间的可能联系。进一步的研究应该使用专门的评估量表来评估人际功能和特定的适应不良特质的水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ef/8235071/431e5e185526/medicina-57-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ef/8235071/8e3664a577fa/medicina-57-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ef/8235071/431e5e185526/medicina-57-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ef/8235071/8e3664a577fa/medicina-57-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ef/8235071/431e5e185526/medicina-57-00628-g002.jpg

相似文献

1
Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).中心性浆液性脉络膜视网膜病变与人格特征:过去 10 年(2010 至 2020 年)科学证据的系统回顾。
Medicina (Kaunas). 2021 Jun 16;57(6):628. doi: 10.3390/medicina57060628.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.

引用本文的文献

1
Treatment of central serous chorioretinopathy: new options for an old disease.中心性浆液性脉络膜视网膜病变的治疗:一种古老疾病的新选择
Eye (Lond). 2025 Jul 4. doi: 10.1038/s41433-025-03894-z.
2
Multiple Bilateral Retinal Pigment Epithelial Detachments in a Patient with Systemic Lupus Erythematosus: A Case Report.系统性红斑狼疮患者的多发性双侧视网膜色素上皮脱离:一例报告
J Curr Ophthalmol. 2024 Mar 29;35(3):287-290. doi: 10.4103/joco.joco_267_22. eCollection 2023 Jul-Sep.
3
Central Serous Chorioretinopathy Risk Factors in An Iranian Cohort: A Case-control Study.

本文引用的文献

1
Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.中心性浆液性脉络膜视网膜病变患者的生活质量——中年人群视力威胁的主要原因。
Arch Med Sci. 2020 Jan 29;17(3):724-730. doi: 10.5114/aoms.2020.92694. eCollection 2021.
2
Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变患者血管生成因子水平的失衡
J Clin Med. 2021 Mar 5;10(5):1087. doi: 10.3390/jcm10051087.
3
Pachychoroid spectrum disease.
伊朗队列中中心性浆液性脉络膜视网膜病变的危险因素:一项病例对照研究。
J Ophthalmic Vis Res. 2023 Nov 30;18(4):410-416. doi: 10.18502/jovr.v18i4.14553. eCollection 2023 Oct-Dec.
4
OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy.光学相干断层扫描(OCT)与OCT血管造影术的进展:在年龄相关性黄斑变性、中心性浆液性脉络膜视网膜病变、黄斑毛细血管扩张症及糖尿病性视网膜病变中的临床应用
Diagnostics (Basel). 2023 Jan 8;13(2):232. doi: 10.3390/diagnostics13020232.
5
Pathomechanisms in central serous chorioretinopathy: A recent update.中心性浆液性脉络膜视网膜病变的发病机制:最新进展
Int J Retina Vitreous. 2023 Jan 20;9(1):3. doi: 10.1186/s40942-023-00443-2.
6
The Temporal Topography of Central Serous Chorioretinopathy in the Chinchilla Rabbits Induced by Intravenous Injection of Adrenaline: An in vivo Study.肾上腺素静脉注射致青紫蓝兔中心性浆液性脉络膜视网膜病变的时相特征:一项在体研究。
Drug Des Devel Ther. 2022 Sep 23;16:3275-3283. doi: 10.2147/DDDT.S381957. eCollection 2022.
7
The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases.光动力疗法在厚脉络膜疾病治疗中的当代作用
J Ophthalmol. 2021 Oct 23;2021:6590230. doi: 10.1155/2021/6590230. eCollection 2021.
8
Mid-Phase Hyperfluorescent Plaques Seen on Indocyanine Green Angiography in Patients with Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变患者吲哚菁绿血管造影术中所见的中期高荧光斑
J Clin Med. 2021 Sep 30;10(19):4525. doi: 10.3390/jcm10194525.
9
Sharing the Same Perspective. Mental Disorders and Central Serous Chorioretinopathy: A Systematic Review of Evidence from 2010 to 2020.观点一致。精神障碍与中心性浆液性脉络膜视网膜病变:2010年至2020年证据的系统评价
Biomedicines. 2021 Aug 23;9(8):1067. doi: 10.3390/biomedicines9081067.
厚脉络膜谱系疾病
Acta Ophthalmol. 2021 Sep;99(6):e806-e822. doi: 10.1111/aos.14683. Epub 2020 Nov 30.
4
Personality of patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者的人格特征。
Eur J Ophthalmol. 2022 Jan;32(1):497-500. doi: 10.1177/1120672120968763. Epub 2020 Nov 5.
5
Differences in anti-endothelial and anti-retinal antibody titers: implications for the pathohysiology of acute and chronic central serous chorioretinopathy.抗血管内皮细胞和抗视网膜抗体滴度的差异:对急性和慢性中心性浆液性脉络膜视网膜病变发病机制的影响。
J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.07. Epub 2020 Jul 13.
6
Cerebral Neurovascular Coupling Impairment in Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变中的脑神经血管耦合损伤。
Ophthalmic Res. 2022;65(4):446-454. doi: 10.1159/000509553. Epub 2020 Jun 19.
7
Increased Risk of Central Serous Chorioretinopathy among Patients with Nonorganic Sleep Disturbance.非器质性睡眠障碍患者发生中心性浆液性脉络膜视网膜病变的风险增加。
J Ophthalmol. 2020 Feb 12;2020:1712503. doi: 10.1155/2020/1712503. eCollection 2020.
8
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study.中心性浆液性脉络膜视网膜病变的国际协作评估:不同治疗方法及文献综述。欧洲玻璃体视网膜学会中心性浆液性脉络膜视网膜病变研究。
Acta Ophthalmol. 2020 Aug;98(5):e549-e558. doi: 10.1111/aos.14319. Epub 2019 Dec 6.
9
Insomnia in personality disorders and substance use disorders.人格障碍与物质使用障碍中的失眠。
Curr Opin Psychol. 2020 Aug;34:72-76. doi: 10.1016/j.copsyc.2019.10.005. Epub 2019 Nov 4.
10
Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.持续性或复发性中心性浆液性脉络膜视网膜病变的危险因素。
J Ophthalmol. 2019 Aug 14;2019:5970659. doi: 10.1155/2019/5970659. eCollection 2019.